Antharis Therapeutics is a biopharmaceutical company developing new treatments for cancer and neurological disorders. In particular, our company utilizes cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs.